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QUANTITATIVE ASSAY OF BINARY AND TERNARY CARDIOVASCULAR MIXTURES
USING ABSORPTION SUBTRACTION SPECTROPHOTOMETRIC METHOD
Abstract
Objective: Development and validation of specific spectrophotometric analytical method for the
simultaneous determination of co-administered cardiovascular mixtures consisting of Aspirine (ASP) and
Prasugrel (PRA) binary mixture and Ticagrelor (TICA), Irbesartan (IRB) and Hydrochlorothazide (HCT)
ternary mixture.
Methods: The proposed spectrophotometric method was based on Absorbance Subtraction, where, when
a mixture of two drugs X and Y having overlapped spectra, intersecting at isoabsorptive point and Y
spectrum is extended more than X, while X doesn’t show any absorbance (A2) at another wavelength (λ2),
X and Y could be determined in the mixture by simple mathematical manipulation
Results: This method obeyed Beer’s law in the concentration range of 5-50 μg/ml for ASP, 5-25 μg/ml for
PRAS, 10-30 μg/ml for TICA, 0.5-2 μg/ml for IRB, 4-10 μg/ml for HCT. The suggested method was applied
on laboratory prepared mixtures and was successfully applied in quality control analysis of combined
pharmaceutical dosage forms. The developed spectrophotometric method was validated statistically and
recovery studies were carried out, where excellent percentage recoveries were obtained. The developed
spectrophotometric method was also compared to reference HPLC methods.
Conclusion: The developed spectrophotometric method based on absorption subtraction is an easy, simple
and time saving method, that was able to determine the active ingredients in the binary and ternary
pharmaceutical formulation without any interference from then excipients.

Keywords
Binary, ternary, cardiovascular mixtures, absorption subtraction method, multicomponent Formulation,
Validation
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1. INTRODUCTION
Cardiovascular drugs often work best in combination, since multiple conditions are behind
most cardiovascular problems. Moreover, multicomponent formulations are gaining interest due
to greater patient acceptability, increased potency, multiple action, fewer side effects, and quicker
relief. Antiplatelet therapy is the cornerstone of treatment for patients with acute coronary
syndrome as it prevents ischemic events in patients undergoing Percutaneous coronary
intervention (Wiviott et al., 2007). Cardiovascular diseases accompanied with high blood pressure
are the largest risk factor for premature death. Some patients with hypertension require two or
more antihypertensive and anti-platelet drugs with complementary mechanisms of action to
control their cardiovascular condition. The angiotensin II type 1-receptor antagonist Irbesatran
(IRB), the diuretic Hydrochlorothiazide (HCT) and the anti-platelet Ticargrelor (TICA) have
recognized clinical efficacy and protective effect on the cardiovascular system. Therefore, the
combination of the three drugs been found to be more effective than either drug alone in the
treatment of cardiovascular diseases not adequately controlled by monotherapy. As well, PRA in
combination with aspirin showed to have more potent antiplatelet effects and faster onset of
activity (Angiolillo et al., 2008). IRB (IRB), chemically described as 2-butyl-3-[[2′-(1H-tetrazol5-yl)[1,1′-biphenyl]-4-yl]-methyl1-3-diazaspiro-[4,4]-non-1-en-4-one, (Fig. 1) is an angiotensin
II blocker, which acts mainly by selective blockade of AT1 receptors and reduces the effects of
angiotensin II. IRB may be used alone or in combination with other antihypertensive or diuretic
agents (O’Neil et al., 2001). Hydrochlorothiazide (HCT), chemically described as 6-chloro-3, 4dihydro-2H-1, 2, 4-benzothiadiazine-7-sulphonamide-1, 1-dioxide, (Fig. 2), is a thiazide diuretic.
It increases sodium and chloride excretion in distal convoluted tubule. Because of their synergistic
anti-hypertensive action, IRB and Hydrochlorothiazide are available in the market as a combined
dosage form (Bank, 2013).
TICA(TICA),
chemically described as (1S,2S,3R,5S)-3-[7-{[(1R,2S)-2-(3,4difluorophenyl)cyclopropyl]amino}-5-(propylthio)-3H-[1,2,3]-tria zolo [4,5-d]pyrimidin-3-yl]5-(2-hydroxyethoxycyclo pentane-1,2-diol2, (Fig. 3), is an orally active antiplatelet agent
indicated to reduce the rate of thrombotic cardiovascular events in patients with acute coronary
syndrome. TICA and its major metabolite reversibly interact with the platelet P2Y12 ADPreceptor to prevent signal transduction and platelet activation, which inhibits platelet aggregation
and thrombus formation in atherosclerotic disease. Aspirin (ASP), chemically described as 2(Acetyloxy) benzoic acid (Fig. 4) is a nonsteroidal anti-inflammatory drug and platelet
aggregation inhibitor. Acetylsalicylic acid binds to acetylates serine residues in cyclooxygenases,
resulting in decreased synthesis of prostaglandin, platelet aggregation, and inflammation
(Vemugunta et al., 2012) PRA (PRA), chemically described as [5-[2-cyclopropyl-1-(2fluorophenyl)-2-oxoethyl]-6, 7-dihydro-4H-thieno [3, 2-c] pyridin-2-yl] acetate hydrochloride
(Fig. 5) is a platelet activation and aggregation inhibitor. PRA is a prodrug that requires enzymatic
transformation in the liver to its active metabolite. Ii irreversibly binds to ADP receptors on
platelets thus preventing activation of the GPIIb/IIIa receptor complex.

Fig.1: Irbesartan
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Fig.2: Hydrochlorobiazide

Fig.3: Ticagrelor
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Fig.4: Aspirin

Fig.5: Prasugrel

Several analytical methods have been reported for the determination of IRB in pure and
pharmaceutical dosage forms using spectrophotometry. Extractive and non-extractive (El Sutohy
et al., 2013) spectrophotometry spectrofluorometry. In presence of hydrochlorothiazide, IRB has
been determined by UV-Spectroscopy. Hydrochlorothiazide has been determined individually by
spectrophotometry. In combination with many other drugs, Hydrochlorothiazide has been
determined by spectrophotometric Chemometric analysis (Farouk et al., 2011; Patel et al., 2011).
Sequential Spectrophotometry (Sridharan et al., 2010). Hydrochlorothiazide was assayed in
combination with many other drugs using H-point standard addition method (Lakshmi et al.,
2011; Sivasubramanian et al., 2015). TICA has been assayed by spectrophotometry (Pendaya et
al., 2016). PRA has been determined individually by extractive spectrophotometry (22),
colorimetric method(Harshini et al., 2011), HPLC (Mullangi et al., 2012; Prabahar et al., 2011)
and HPTLC (Damle et al., 2017). In combination with ASP, PRA has been determined by HPLC
(Patel et al., 2013; Martos et al., 2000), spectrophotometry (Chhonker et al., 2016),
spectrofluorimetry (Porwal et al., 2015). ASP has been determined in presence of Clopidogrel in
human plasma (Lotfy, 2014). ASP has been determined in presence of many other drugs by LC
and HPLC. In this work, green analytical spectrophotometric method has been developed for the
analysis of PRA and ASP binary combination and IRB, TICA and HCT ternary combination in
synthetic mixtures and laboratory made tablets. The suggested spectrophotometric method is able
to resolve the overlapped spectra by simple manipulation step, the absorbance values
corresponding to the studied drugs could be easily obtained. The spectrophotometric method was
validated according to ICH guide lines and the results were compared to reference RP-HPLC
methods.

2. METHODOLOGY
2.1 Theoretical Background
The Absorbance Subtraction method is based on the same principle as the absorption
factor method (Lotfy, 2014) and it depends on that, if you have a mixture of two drugs X and
Y having overlapped spectra, intersecting at isoabsorptive point and Y is extended more than
X, while X doesn’t show any absorbance (A2) at another wavelength (λ2), X and Y could be
determined in the mixture by simple mathematical manipulation. In the absorbance
subtraction method (AS) the isoabsorptive point (λiso) could be used for the separate
quantitative determination of each X & Y in their mixture (X+Y). The determination can be
done using mathematically calculated factor of one of these components. So, the
Concentration of each component could be obtained via the isoabsorptive point regression
equation without any need for a complementary method. The absorbance values
corresponding to X and Y at λiso were calculated by using absorbance factor {Aiso / A2}
which is a constant for pure Y representing the average of the ratio between the absorbance
values of different concentrations of pure Y at λiso divide be the absorbance values of pure Y
at λ2.
Absorbance of Y in the mixture at λiso = Ay λiso/ Ay λ2 × A(x+y) λ2.
Absorbance of X in the mixture at λiso = A(x+y) λiso – (Ay λiso / Ay λ2) × A(x+y) λ2.

https://digitalcommons.bau.edu.lb/hwbjournal/vol3/iss1/8

2

al: QUANTITATIVE ASSAY OF BINARY AND TERNARY CARDIOVASCULAR MIXTURES USING ABSORPTION SUBTRACTION SPECTROPHOTOMETRIC ME

Where; Ay λiso and Ay λ2 is the absorbance value of pure Y at λiso and λ2; Ay λiso/
Ay λ2 is called the absorbance factor and abs λiso (X + Y) and abs λ2(X + Y) are the
absorbance of the mixture at these wavelengths (λiso, λ2).
The concentration of each of X or Y is separately calculated using the isoabsorptive
point regression equation that is obtained by plotting the absorbance values or the ratio signals
of X or Y at isoabsorptive point (λiso) against their corresponding concentrations.

2.2 MATERIALS AND METHODS
Apparatus
The spectrophotometric measurements were carried out on a Jasco V-530 double beam
UV-Vis Spectrophotometer connected to a computer loaded with Jasco UVPC software and
HP Deskjet 5652 printer. The spectrophotometer is supported with Jasco Spectra Manager
software for GULLIVER Ver. 1.53. The absorption spectra were recorded using 1 cm quartz
cells.
Chemicals
Aspirin and PRA (supplied by SIGMA-ALDRICH) were used as working standards.
TICA(supplied by Omnipharma, Astrazenica, Lebanon), IRB and Hydrochlorothiazide
(supplied by Algorithm, Lebanon). Methanol (supplied by SIGMA-ALDRICH
CHROMASOLV® FOR HPLC>99.9%) was used as solvent.
Standard stock solutions
The standard stock solutions were separately diluted with methanol to prepare working
standards having the concentrations of 100 µg.mL-1 TICA, 10 µg.mL-1 IRB, 40µg.mL-1
HCT, 100 µg.mL-1 ASP and 100 µg.mL-1 PRA.
Working standard solutions
Standard solutions of TICA (1000 µg.mL-1), IRB (100 µg.mL-1), HCT(400 µg.mL-1),
ASP (1000 µg.mL-1) and PRA (400 µg.mL-1) were separately prepared using methanol as
solvent.
Calibration graphs
Into series of 10-mL measured flasks, volumes from the above prepared working
standard solutions of ASP, PRA TICA, IRB or HCT, were separately transferred and diluted
with methanol to give the final concentrations stated in Table 1.
Synthetic mixtures
Six validation synthetic mixtures from the binary and ternary mixtures were prepared
by mixing appropriate volumes of the working standard solutions of ASP and PRA or TICA,
IRB and HCT and diluting to volume with methanol. The combination of ASP and PRA or
TICA, IRB and HCT are illustrated in Table 2.
The absorbance values for each solution of the calibration graph and the prepared
synthetic mixtures were recorded at 1-nm intervals in the wavelength range 200-300 nm
For ASP and PRA determination, the A spectra of the standard solutions and their
mixtures were recorded at 223 and 256 nm.
For TICA and HCT determination, the ratio spectra of the standard solutions and their
mixtures were recorded at 214 and 240 nm, where the ratio spectra are obtained by dividing
the absorption spectra of the three analyte and their mixtures by the spectra of 0.5 µg.mL-1
IRB standard solution).
For IRB and HCT determination, the ratio spectra of the standard solutions and their
mixtures were recorded at 229 and 240 nm, where the ratio spectra are obtained by dividing
the absorption spectra of the three analyte and their mixtures by the spectra of 12.5 µg.mL-1
TICA standard solution).
Regression equations of the signals obtained versus the standard concentration of
analyte are derived to quantify each of the studied drugs in their binary or ternary mixtures.
Published by Digital Commons @ BAU, 2020
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Laboratory made tablets
Accurately two sets of ten laboratory made tablets; the first set containing 100 mg ASP
and 10 mg PRA per tablet, and the second set containing 90 mg TICA, 15 mg IRB and 50 mg
HCT per tablet (in addition to lactose, starch, talc and magnesium stearate as tablet fillers)
were weighed and powdered. Accurate weight (equivalent to 10 mg ASP and 1 mg PRA) or
(equivalent to 9 mg TICA, 1.5 mg IRB and 5 mg HCT) of the finely powdered tablets were
transferred into two separate 100-mL calibrated flasks, 50 mL methanol were added and the
flasks were shaken for 15 min, filtered and completed to volume with methanol. 1-mL of each
of the prepared solutions, was transferred into two separate 10-mL calibrated flask and diluted
to volume with methanol to prepare tablet solutions containing 5 μg.mL-1 PRA and 50 μg.mL1 ASP or 9 μg.mL-1 TICA, 1.5 μg.mL-1 IRB and 5 μg.mL-1 HCT. The absorption spectra of
the prepared tablet solutions were scanned from 200-300 nm against methanol as a blank.

3. RESULTS
Spectral characteristics
Quantitative analysis often involves the spectrophotometric resolution of mixtures of two
or more components with partly overlapping spectra. The extensive overlapping between the
absorption spectra of ASP and PRA and TICA, IRB and HCT in Fig. 6 and Fig. 7 respectively is
sufficiently clear, making the resolution using the direct UV-Vis spectrophotometry more difficult.
Thus, the need for the development of mathematical treatment of the data. Absorption subtraction
method is one of the easily applied method in which minimal treatment of the data is done. This
method could be used if there is existence of an isoabsorptive point for the drugs in mixture and
extension of the spectra of the other component.
A
0.9
0.7
0.6

0.4
0.3
0.1
-0.1

215

225

235

ASP

245

255

PRA

265

275

Their mixture

285
295
Wavelength(nm)

Fig.6: Absorption curves of 10 μg.mL-1 ASP and 15 μg.mL-1 of PRA in methanol
1.2

A

1
0.8
0.6
0.4
0.2
0
200

210

220

230

IRB

HCT

240

250

260
TICA

270

280

Wavelength (nm)

Fig.7: Absorption curves of 12.5 μg.mL-1 TICA, 0.5 μg.mL-1 IRB and 4 μg.mL-1 of HCT in methanol
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4. DISCUSSION
Fig. 6 shows that the A spectra of ASP and PRA exhibit an isoabsorptive point at 223 nm
and it is also clear that the A spectrum of ASP is more extended in the spectral region between
245-260 nm, Thus the AS method could be applied for the determination of ASP and PRA in
presence of each other. By the analysis of the recorded A values for ASP, PRA and their mixture
at 223 nm and 256 nm, the ratio signals of ASP and PRA could be separately calculated from the
following equations:
Absorbance of PRA in the mixture at λ223 = APRAS λ223/ APRAS λ256 × A(ASP+PRAS) λ256.
Absorbance of ASP in the mixture at λ223 = A(ASP+PRA) λ223 – (APRA λ223 / APRA λ256)×
A(ASP+PRA) λ256,
Where, the APRA λ223 / APRA λ256 is the absorbance factor of pure PRA at 223 and 256 nm.
To be able to quantify TICA or HCT, in their ternary mixture, AS method, has been
developed on the ratio spectra (Fig. 8); where the effect of IRB has been eliminated by dividing
the zero absorption spectrum of the mixture by the zero order spectrum of a standard IRB solution.
Upon this division, constant spectrum equivalent to the contribution of IRB in the mixture is
generated (AIRB/ A IRB0). Subtracting the value of this constant from the ratio spectrum, will
give ratio signals equivalent to TICA and IRB only. On the obtained ratio signals, SA method has
been applied to determine the concentration TICA and HCT.
Fig. 8 shows that the ratio spectra of TICA and HCT, exhibit an isoabsorptive point at 214
nm and it is also clear that the ratio spectrum of HCT is more extended in the spectral region
between 235-245 nm, Thus the AS method could be applied for the determination of TICA and
HCT in presence of each other. By the analysis of the recorded ratio signals for TICA, HCT and
their mixture at 214 nm and 240 nm, the ratio signals of TICA and HCT could be separately
calculated from the following equations:
Ratio signal of TICA in the mixture at λ214 = RTICA λ214/ RPTICA λ240 × R(TICA+HCT)
λ240.
Ratio signal of HCT in the mixture at λ214= R(TICA+HCT) λ214 – (RTICAλ214 / RTICA λ240)
× R(TICA+HCT) λ240,
Where, the RTICA λ214 / RTICA λ240 is the absorbance factor of pure TICA at 214 and 240 nm.

Ratio
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Fig.8: The ratio spectra of 4 µg/mL HCT and 12.5 µg/mL TICA, divided by the spectra of 0.5 µg/mL IRB
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To be able to quantify IRB in its ternary mixture, AS method, has been developed on the
ratio spectra (Fig. 9); where the effect of TICA has been removed by dividing the zero absorption
spectrum of the mixture by the zero order spectrum of a standard TICA solution. Upon this
division, constant spectrum equivalent to the contribution of TICA in the mixture is generated
(ATICA/ A TICA0). Subtracting the value of this constant from the ratio spectrum, will give ratio
signals equivalent to TICA and IRB only. On the obtained ratio signals, SA method has been
applied to determine the concentration IRB and HCT.
Fig. 9 shows that the ratio spectra of IRB and HCT, exhibit an isoabsorptive point at 229
nm and it is also clear that the ratio spectrum of HCT is more extended in the spectral region
between 235-245 nm, Thus the AS method could be applied for the determination of IRB and HCT
in presence of each other. By the analysis of the recorded ratio signals for IRB, HCT and their
mixture at 229 nm and 240 nm, the ratio signals of IRB and HCT could be separately calculated
from the following equations:
Ratio signal of IRB in the mixture at λ229 = RIRB λ229/ RIRB λ240 × R (IRB+HCT) λ240.
Ratio signal of HCT in the mixture at λ229= R (IRB+HCT) λ229 – (RTICAλ229 / RTICA λ240)
× R(IRB+HCT) λ240,
Where, the RIRB λ229 / RIRB λ240 is the absorbance factor of pure IRB at 229 and 240 nm.
Ratio
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Fig.9: The ratio spectra of 0.5 µg/mL IRB and 4 µg/mL HCT, divided by the spectra of 12.5 µg/mL TICA

Method validation and statistical analysis
The proposed method was validated according to ICH guidelines. The validation parameters
included: linearity, limits of detection and quantification, accuracy, precision and specificity. The
applied specrophotometric analytical method was able to quantify the studied drugs in their double
and ternary mixtures.
Linearity and concentration ranges
Under the described experimental conditions, the graphs obtained by plotting the signals of
the proposed method versus concentration for ASP, PRA, TICA, IRB and HCT gave linear
relationships over the concentration ranges stated in Table 1. Linearity data and statistical
parameters for the proposed method were calculated, including linear regression equation
parameters (intercepts, slopes, correlation coefficients, standard deviation of intercept and
standard deviation of the slope (Table 1). Regression analysis confirmed good linearity as shown
from correlation coefficient value (r> 0.999). The high F-value proved that the linear correlation
between calculated signals (spectrophotometric method) and concentrations in significant to a high
level of confidence. The high values of the correlation coefficient (r) with negligible intercepts
indicate the good linearity of the calibration graphs. Standard deviation of residuals (Sy/x), of
intercept (Sa) and of slope (Sb) are presented for each drug. (Sy/x) is a measure of the extent of
deviation of the found (measured) y-values from the calculated ones. Also, the small degree of
scatter of the experimental data point around the line of regressions was confirmed by the small
values of the variances around the slopes (Sb2).
https://digitalcommons.bau.edu.lb/hwbjournal/vol3/iss1/8
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Limit of detection (LOD) and limit of qualification (LOQ)
Limits of detection (LOD) and quantification (LOQ) were calculated according to the ICH
guidelines (33). LOD was defined as 10 Sa/b, where Sa is the standard deviation of the intercept
and b is the slope of the calibration curve. The sensitivity of the proposed methods can be
confirmed by the low LOD and LOQ values obtained in Table 1. The variance test for the
regression lines revealed that, for equal degrees of freedom, the increase in the variance ratio (Fvalues) means an increase in the mean squares due to regression and a decrease in the mean squares
due to residuals, (the less is the scatter of experimental points around the regression line).
Consequently, regression lines with high F-values (low significance F) are much better than those
with lower ones. Good regression lines show high values for both r and F statistical parameters
(Armitage et al., 2008).
Accuracy
The applicability of the developed method was tested by the analysis of ASP-PRA and
TICA-IRB-HCT in several synthetic mixtures of different proportions. Each solution was
measured in triplicate, and the recoveries were calculated. Good accuracy, expressed as percentage
relative error (Er %) were obtained. The results, summarized in Table 2 show that the calculated
(Er %) values do not exceed the accepted limits, which demonstrate the high accuracy of the
developed methods.
Precision
Intra-day precision was determined by analyzing the prepared mixtures for five times in the
same day. Inter-day precision was determined by analyzing the prepared mixtures individually for
three successive days. High precision expressed as % RSD were obtained. The results are
summarised in Table 3 where the values of % RSD did not exceeded the accepted limits which
demonstrate the precision of the method.
Laboratory made mixtures
Table 4 presents a statistical comparison between the proposed method and a reference RPHPLC method for the assay of ASP and PRA binary combination, TICA, IRB and HCT ternary
combination by using the student’s t-test and the variance ratio F-test. Since the calculated t- and
F- values for each drug did not exceed the theoretical ones, this indicated that there was no
significant difference between the applied methods for determination of the two drugs in
commercial tablets.
Table 1: Assay parameters for the determination of ASP, PRA, TICA, IRB or HCT in their binary or
ternary mixtures using the Absorption subtraction method
ASP

PRA

PRA

TICA

TICA

IRB

IRB

HCT

5-50

5-25

5-25

10-30

10-30

0.5-3

0.5-3

4-10

r

223
0.9995

223
0.9986

256
0.9998

229
0.999

240
0.9990

229
0.9995

240
0.9983

229
0.9991

S y/x

0.16 x10-2

0.39 x10-3

1.56 x10-5

0.40 x10-3

0.19 x10-3

1.15 x10-3

1.81 x10-3

0.15 x10-3

F

3263

1120

11654

1642

1564

3110

892

1192

Significance F

1.18 x10-5

5.86 x10-5

1.75 x10-6

3.30 x10-5

3.55 x10-5

1.27 x10-5

8.23 x10-5

0.83 x10-3

x10-1

x10-1

x10-1

x10-1

x10-1

x10-1

0.15 x10-1

Conc.
(µg.mL-1)
λ (nm)

Range

a (intercept)

-0.11

b (slope)

0.42 x10-1

0.24 x10-1

0.15 x10-1

0.29 x10-1

0.20 x10-1

0.24

x10-1

0.12

x10-1

0.23

x10-2

0.15

x10-1

0.11

x10-1

Sb

0.74

x10-3

0.72

x10-3

0.14

x10-3

0.73

x10-3

0.51

x10-3

LOD (µg/mL)

1.74

1.48

0.46

1.57

LOQ (µg/mL)

5.80

4.90

1.50

a/Sa

-0.43

1.71

0.96

Sa

(Sb

)2

Sb %

5.52

x10-7

0.74

x10-1

0.21

5.24

x10-7

0.72

x10-1

Published by Digital Commons @ BAU, 2020

0.23

x10-2

2.08

x10-8

0.14

x10-1

-0.10

-0.15

-0.18
0.56

0.28

0.66 x10-1

0.38

0.18

x10-1

0.23

x10-1

0.11

x10-1

0.12

x10-1

1.60

0.97 x10-1

0.18

0.63

5.20

5.36

0.32

0.61

2.12

-0.64

-1.37

-0.99

1.24

5.33

x10-7

0.73

x10-1

2.63

x10-7

0.10

0.51

x10-1

1.02

x10-3

0.16
1.27

0.14 x10-1
0.19 x10-2

1.05
x10-3

3.75 x10-6
0.19

7

BAU Journal - Health and Wellbeing, Vol. 3, Iss. 1 [2020], Art. 8

Table 2: Assay results for the determination of ASP-PRA and TICA-IRB-HCT and in
synthetic mixtures using the Absorbance subtraction method.
Mean Recovery ± SDa
RSD %b
Er %c
ASP:PRA
µg.mL-1

TICA: IRB:HCT
µg.mL-1

100.00± 0.86
0.86
0.00
100.79 ± 0.34
5:25
0.33
0.79
100.91± 1.78
10:20
1.76
0.91
98.76 ± 0.45
20:15
0.45
-1.01
98.00 ± 1.41
30:10
1.44
-2.00
101.24 ± 0.99
40:5
0.97
1.24
a Mean ± SD for the three determinations
b % Relative standard deviation
c % Relative error
50:5

100.00± 0.86
0.86
0.00
100.79 ± 0.34
0.33
0.79
100.91± 1.78
1.76
0.91
98.76 ± 0.45
0.45
-1.01
96.62 ± 0.73
0.75
-3.38
101.24 ± 0.99
0.97
1.24

10:0.5:10

15:3:6

20:1:4

20:3:8

20:2.5:6

30:3:10

Table 3: Intra-day and inter-day precision for the simultaneous determination of ASP and PRA, TICA,
IRB and HCT, in laboratory-made mixtures using the proposed RP-HPLC methods

ASP:PRA
μg.mL-1

50:5
TICA: IRB:
HCT μg.mL-1

9 : 1.5 : 5

Intra-day precision
Mean Recovery ± SDa
RSD%b
Er%c

Inter-day precision
Mean Recovery ± SDa
RSD%b
Er%c

ASP

PRA

ASP

98.21±1.93
1.96
-1.01
Intra-day precision
Mean Recovery ± SDa
RSD%b
Er%c

99.44 ± 1.38
1.38
-0.51

99.01 ± 0.98
98.64 ± 0.77
0.99
0.78
-0.99
-1.36
Inter-day precision
Mean Recovery ± SDa
RSD%b
Er%c

PRA

TICA

IRB

HCT

TICA

IRB

HCT

99.82 ± 0.83
0.83
-0.18

99.32 ± 1.07
1.07
-0.68

101.21 ± 0.86
0.85
1.21

100.26 ± 0.92
0.92
0.26

100.39 ±
0.86
0.86
0.39

98.92
± 0.98
0.99
-0.58

a Mean

± SD for the five determinations
Relative standard deviation
c% Relative error
b%
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Table 4: Assay results for ASP-PRA and TICA-IRB-HCT in their laboratory made tablets using the
proposed Absorption subtraction method
Ratio
ASP:PRA
50:5
µg/mL

Mean Recovery ± SDa
RSD %b
Er %c
HPLC (28)
99.58 ± 0.60
0.60
-0.42

AS
98.63±0.85
0.86
-1.37

**t-test
**F-test
PRA

––
––
99.48 ± 0.46
0.46
-0.52

-2.04
2.00
98.56±0.89
0.90
-1.44

**t-test
**F-test
Ratio
TICA : IRB : HCT
9 : 1.5 : 5
µg/mL

––
––

0.70
3.74

ASP

Mean Recovery ± SDa
RSD %b
Er %c
HPLC(37)
98.76 ± 0.45
0.45
-1.24

AS
98.99 ± 0.87
0.87
-1.01

**t-test
**F-test
IRB

––
––
98.99 ± 0.87
0.87
-1.01

0.53
3.73
99.30 ± 0.65
0.88
-1.24

**t-test
**F-test
HCT

––
––
99.08 ± 0.61
0.61
-0.92

0.64
0.56
98.71 ± 1.10
0.67
-0.29

**t-test
**F-test

––
––

TICA

0.56
3.25

a

Mean ± SD for the five determinations
% Relative standard deviation
c
% Relative error
**Theoretical values of t- and F- at P = 0.05 are 2.13 and 6.93, respectively
b

5. CONCLUSION
For analytical purposes, it is always important to establish methods capable of analysing co
administered drugs in short period of time with acceptable accuracy and precision. The developed
spectrophotometric method is simple, inexpensive, require easy treatment of the samples and is
based on simple mathematical and statistical background. The Absorption subtraction method
demonstrated its ability to resolve the binary and ternary co-administered mixtures and
individually quantify each of their components. The Absorption subtraction method could be well
adopted since it gave satisfactory results in the analysis of synthetic mixtures, and proved to be
sensitive, selective, accurate and precise and can be applied for different concentration ratios.
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